[ Price : $8.95]
Vertex Pharmaceuticals says an interim analysis of its Phase 3 RAINIER trial showed its experimental therapy povetacicept signific...[ Price : $8.95]
FDA accepts for review a Capricor Therapeutics BLA resubmission for its experimental cell therapy deramiocel, intended to treat he...[ Price : $8.95]
FDA approves an expanded use of GSKs Wellcovorin (leucovorin calcium) tablets for treating cerebral folate deficiency in adult and...[ Price : $8.95]
Xenon Pharmaceuticals says its experimental epilepsy drug azetukalner met the primary endpoint in a late-stage clinical trial in p...[ Price : $8.95]
FDA posts an updated draft guidance outlining new and revised recommendations for companies developing biosimilar products.[ Price : $8.95]
FDA sends Incyte a complete response letter for its supplemental BLA for Zynyz (retifanlimab-dlwr) injection that cited inspectio...[ Price : $8.95]
Consumer advocacy group Public Citizen urges Pfizer to commit to maintaining access to its medicines in Europe after comments by C...[ Price : $8.95]
Roche reports that its investigational breast cancer drug giredestrant failed to significantly extend progression-free survival in...